Multivariate analysis and model building for classifying patients in the peroxisomal disorders X-linked adrenoleukodystrophy and Zellweger syndrome in Chinese pediatric patients
Open Access
- 2 May 2023
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 18 (1) , 1-14
Abstract
Background: The peroxisome is a ubiquitous single membrane-enclosed organelle with an important metabolic role. Peroxisomal disorders represent a class of medical conditions caused by deficiencies in peroxisome function and are segmented into enzyme-and-transporter defects (defects in single peroxisomal proteins) and peroxisome biogenesis disorders (defects in the peroxin proteins, critical for normal peroxisome assembly and biogenesis). In this study, we employed multivariate supervised and non-supervised statistical methods and utilized mass spectrometry data of neurological patients, peroxisomal disorder patients (X-linked adrenoleukodystrophy and Zellweger syndrome), and healthy controls to analyze the role of common metabolites in peroxisomal disorders, to develop and refine a classification models of X-linked adrenoleukodystrophy and Zellweger syndrome, and to explore analytes with utility in rapid screening and diagnostics.Results: T-SNE, PCA, and (sparse) PLS-DA, operated on mass spectrometry data of patients and healthy controls were utilized in this study. The performance of exploratory PLS-DA models was assessed to determine a suitable number of latent components and variables to retain for sparse PLS-DA models. Reduced-features (sparse) PLS-DA models achieved excellent classification performance of X-linked adrenoleukodystrophy and Zellweger syndrome patients.Conclusions: Our study demonstrated metabolic differences between healthy controls, neurological patients, and peroxisomal disorder (X-linked adrenoleukodystrophy and Zellweger syndrome) patients, refined classification models and showed the potential utility of hexacosanoylcarnitine (C26:0-carnitine) as a screening analyte for Chinese patients in the context of a multivariate discriminant model predictive of peroxisomal disorders.Keywords
Funding Information
- The Clinical Research Plan of SHDC (SHDC2020CR6028)
- the Science and Technology Commission of Shanghai Municipality (22Y11906900)
- the Open Foundation of Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province (the Open Foundation of Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province)
- Chulalongkorn University (Chulalongkorn University)
- the Interdisciplinary Program of Shanghai Jiao Tong University (YG2022QN097)
- Shanghai Children's Hospital (2021YGZQ09)
This publication has 42 references indexed in Scilit:
- X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and managementOrphanet Journal of Rare Diseases, 2012
- Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problemsBMC Bioinformatics, 2011
- MTML-msBayes: Approximate Bayesian comparative phylogeographic inference from multiple taxa and multiple loci with rate heterogeneityBMC Bioinformatics, 2011
- Lovastatin in X-Linked AdrenoleukodystrophyNew England Journal of Medicine, 2010
- Canonical partial least squares—a unified PLS approach to classification and regression problemsJournal of Chemometrics, 2009
- A Sparse PLS for Variable Selection when Integrating Omics DataStatistical Applications in Genetics and Molecular Biology, 2008
- From dummy regression to prior probabilities in PLS‐DAJournal of Chemometrics, 2007
- Partial least squares for discriminationJournal of Chemometrics, 2003
- Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"Journal of Neurology, Neurosurgery & Psychiatry, 1999
- Partial least squares analysis with cross‐validation for the two‐class problem: A Monte Carlo studyJournal of Chemometrics, 1987